Moreover, inhibition of ALDH1 tended to block tumor metastasis to the brain (Supplementary Fig. S3E) There was no notable toxicity measured on the basis of body weight change when disulfiram was combined to overcome the acquired resistance to erlotinib (Supplementary Fig. S3F). Here, ALDH1A1 is linked to neoplasm.